Cibus Reports Second Quarter 2023 Financial Results and Provides Business Update - Cibus (NASDAQ:CBUS)
Two gene editing pioneers closed merger to create a leading agricultural gene editing company with an expanded portfolio of patents, patents pending, and exclusive licenses to core technologies for gene editing of